Table 2 Clinical characteristics and fasting serum N-terminal pro-B-type natriuretic peptide levels of 84 elderly persons
Characteristic | Number (%) | NT-proBNP (pg/ml) | P value | |
|---|---|---|---|---|
Gender | Male | 28 (33.3) | 173.50 ± 227.45 | 0.284 |
Female | 56 (66.7) | 290.14 ± 302.88 | ||
Diabetes | No | 54 (64.3) | 218.80 ± 275.99 | 0.636 |
Yes | 30 (35.7) | 269.30 ± 289.92 | ||
Hypertension | No | 16 (19.1) | 336.25 ± 370.62 | 0.223 |
Yes | 68 (80.9) | 231.26 ± 260.74 | ||
Metabolic syndrome | No | 46 (54.8) | 384.87 ± 342.22 | 0.001* |
Yes | 38 (45.2) | 89.53 ± 55.88 | ||
ACE inhibitor | No | 68 (80.9) | 236.53 ± 281.99 | 0.748 |
Yes | 16 (19.1) | 313.88 ± 296.03 | ||
ARB | No | 40 (47.6) | 306.30 ± 315.87 | 0.251 |
Yes | 44 (52.4) | 201.23 ± 245.44 | ||
β-blocker | No | 46 (54.8) | 262.09 ± 310.44 | 0.622 |
Yes | 38 (45.2) | 238.16 ± 252.79 | ||
CCB | No | 38 (45.2) | 326.26 ± 325.47 | 0.100 |
Yes | 46 (54.8) | 189.30 ± 231.05 | ||
Statin | No | 64 (76.2) | 276.50 ± 306.19 | 0.506 |
Yes | 20 (23.8) | 170.50 ± 177.76 | ||
Fibrate | No | 74 (88.1) | 264.46 ± 296.72 | 0.938 |
Yes | 10 (11.9) | 168.40 ± 130.17 | ||
Sulfonylurea | No | 76 (90.5) | 265.50 ± 293.33 | 0.780 |
Yes | 8 (9.5) | 116.00 ± 62.79 | ||
Metformin | No | 66 (78.6) | 249.15 ± 268.06 | 0.690 |
Yes | 18 (21.4) | 259.00 ± 349.32 | ||